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ABSTRACT: Knowledge of the ability of the female reproductive system to metabolize polycyclic aromatic
hydrocarbons (PAHs) is critical to the diagnosis and management of female infertility and for risk assessment purposes. The PAHs are a family of widespread pollutants that are released into the environment
from automobile exhausts, cigarette smoke, burning of refuse, industrial emissions, and hazardous waste
sites. In exposed animals, PAHs become activated to reactive metabolites that interfere with target organ
function and as a consequence cause toxicity. The extent of susceptibility to PAH exposure may depend
on the ability of animals to metabolize these chemicals. The present study has been undertaken to assess
whether any differences exist among mammals in the metabolism of benzo(a)pyrene (BaP), a prototypical
PAH compound. Microsomes isolated from the liver and ovaries of rats, mice, goats, sheep, pigs, and
cows were incubated with 5 lM BaP. Postincubation, samples were extracted with ethyl acetate and analyzed for BaP/metabolites by reverse-phase HPLC with ﬂuorescence detection. The rate of metabolism
(pmol of metabolite/min/mg protein) was found to be more in liver than in ovary in all the species studied
(P \ 0.05). The differences in metabolite concentrations were statistically signiﬁcant (P \ 0.0001) among
the various species in both organs studied. Multiple species comparison also revealed that the differences
were statistically signiﬁcant (P \ 0.001) between rodents (rat and mouse) and higher mammals (ewe, sow,
and cow). Even among the higher mammals, in a majority of the cases, the differences in metabolite concentrations were signiﬁcantly different (P \ 0.001) both in ovary and liver. The BaP metabolites identiﬁed
were 4,5-diol; 7,8-diol; 9,10-diol; 3-hydroxy BaP; and 9-hydroxy BaP. The rodent microsomes produced
considerably higher proportion of BaP 4,5-diol and 9,10-diol than did cow, sow, goat, and sheep.
However, microsomes from higher mammals converted a greater proportion of BaP to 3-hydroxy and
9-hydroxy BaP, the detoxiﬁcation products of BaP. Overall, our results revealed a great variation among
species to metabolize BaP. # 2008 Wiley Periodicals, Inc. Environ Toxicol 24: 603–609, 2009.
Keywords: benzo(a)pyrene; polycyclic aromatic hydrocarbons; ovarian microsomes; liver microsomes;
metabolism; HPLC
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In recent years, environmental toxicants have been implicated in various reproductive disorders in humans
(Younglai et al., 2007). The difﬁculties encountered in
studying the mechanism of action of environmental chemicals on human reproduction necessitate employing
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laboratory animals and animal models for mechanistic
reproductive studies (WHO, 2001). Therefore, understanding the mechanism by which environmental toxicants are
metabolized in the female reproductive system of animals
will be of importance in the diagnosis and management of
female fertility issues. Additionally, in reference to environmental health issues, chemical-speciﬁc metabolism data
will aid in the generation of a compendium of interspecies
default factors used for risk assessment (Walton et al.,
2001).
Some of the environmental chemicals act as reproductive toxicants in that they bind to the receptors necessary
for the regulation of reproductive organs, thus contributing
to impairment in sexual behavior, gamete function, and
delivery of the new born. One such environmental chemical
that has been categorized as a reproductive toxicant is benzo(a)pyrene (BaP; Charles et al., 2000; Archibong et al.,
2002; Inyang et al., 2003; Ramesh et al., 2008). Automobile
exhausts, cigarette smoke, biomass burning, charcoalbroiled meat, industrial emissions, municipal incinerators,
and hazardous waste sites contribute considerable amounts
of this chemical (IPCS, 1998) to human exposure. In
exposed animals and humans, BaP becomes activated in
organs particularly the ovaries, to reactive metabolites that
interfere with the latter organ function (reviewed in Ramesh
et al., 2004) and as a consequence cause ovarian failure.
The rationale for conducting this study was to assess the
qualitative and quantitative differences among different
mammalian species in ovarian and hepatic microsomal metabolism of BaP, a prototypical polycyclic aromatic hydrocarbon (PAH) compound. Association has been established
between the substantially higher levels of PAH exposures
with increased incidence of female reproductive toxicity in
laboratory animals (Borman et al., 2000; Jurisicova et al.,
2007; Tsai-Turton et al., 2007) and humans (Matikainen
et al., 2001; Neal et al., 2007). Therefore, information on
the ability of these mammals to metabolize BaP will be
useful for assessing risks to humans arising from different
sources of exposure to this PAH (occupational, environmental exposures, and consumption of contaminated
meats).

MATERIALS AND METHODS
Test Species/Tissue Samples
Microsomes were isolated from the liver and ovarian tissues of the following animals: rat (age 5 10 weeks), mouse
(age 5 10 weeks), sheep (age 5 20–30 months), goat (age
5 16–24 months), pig (age 5 9 months), and cow (age 5
36 months).
Pig ovary and liver samples were obtained from the
USDA Meat Animal Research Center, Clay Center, NE;
cow, sheep, and goat ovary and liver samples were obtained
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from abattoirs in and around Nashville, TN. Similar organ
samples from rat and mouse were obtained from animals
maintained in-house. All animals used in this study were
mature and healthy and were not subjected to any form of
treatment/medication. Except for tissue samples collected
from the abattoirs, the rest of the tissues used in this study
were collected from animals whose uses for experiments
were approved by the respective Institutional Animal Care
and Use Committees.

Preparation of Microsomes
Ovary and liver samples from autopsied animals (rat and
mouse), and animals from the USDA facility and abattoirs
after sacriﬁce and evisceration (cow, sheep, goat, and pig)
were immediately frozen on dry ice and stored at 2708C
until isolation of microsomes. Microsomal fraction preparation and analysis were conducted simultaneously on tissues
from representative species mentioned above, in order to
minimize procedural variations. A minimum of ﬁve samples/organ/species were used for analysis.
Microsomal fractions were prepared, and processed as
described by Schenkman and Jansson (1999) with some
modiﬁcations. The connective tissues surrounding the
ovary and fat on liver samples were removed following
which, they were washed in chilled (48C) isotonic saline to
remove excess blood. Each ovary and liver samples were
individually cut into small pieces using sterile scalpel
blades, minced separately with a ﬁne pair of scissors and
thoroughly mixed to obtain a homogenous mixture of
minced tissue samples per animal. One gram of each
minced sample was chilled in isotonic saline for 5 min prior
to being homogenized in two volumes of sucrose-TKM
buffer (sucrose 0.25 M, Tris 80 mM, KCl 25 mM, MgCl2 5
mM, pH 7.4). Each minced tissue sample homogenate was
centrifuged at 10 000 3 g for 10 min, supernatant harvested
and subjected to a second centrifugation at 15 000 3 g for
15 min to pellet down nuclei and mitochondria. Each resultant supernatant was centrifuged at 100 000 3 g for 60 min
at 48C following which, the cytosolic supernatant and
microsomal pellet were separated. Each microsomal pellet
was rinsed twice with 5 mL of sucrose-TKM buffer and
resuspended in 5 mL of the same buffer. Ovarian or liver
microsomes were aliquoted into cryovials (Wheaton Science Products, Millville, NJ), and stored frozen at 2808C
until used for studying BaP metabolism. Protein content of
each microsomal preparation was determined according to
the method of Bradford (1976).

Microsomal Incubations and
Metabolism Studies
Pilot studies were conducted to establish optimal conditions for microsomal protein concentration, substrate
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concentration, and time of incubation of reaction mixtures
in the assay. The results (data not shown here) showed that
reaction rates were consistent with linearity of metabolism
occurring in the ﬁrst 15 min, at microsomal protein and
substrate concentrations of 0.5 mg/mL and 5 lM,
respectively.
Before conducting metabolism studies, microsomes
were thawed at room temperature and 120 lL of the microsomal pellet resuspended in TKM buffer (ﬁnal protein concentration 5 0.5 mg/mL) were added to 5 mL of cocktail
containing NADPH (0.72 mM), EDTA (100 mM), KPO4
(100 mM), MgCl2. 6H2O (3.75 mM). Samples per animal
were preincubated for 2 min at 378C in a tissue shaker (Precision Scientiﬁc Instruments, Chicago, IL) prior to being
distributed to a treatment and a control reaction tubes in a 2
3 3 3 7 factorial arrangement (two organs, three classes of
treatment, and seven species). Treatment consisted of exposure in vitro to 5 lM BaP (CAS No. 50-32-8; 98% pure,
Sigma Chemical Co., St. Louis, MO) dissolved in dimethyl
sulfoxide. After 15 min incubation at 378C, the reaction
was stopped with 8 mL of ethyl acetate containing butylated hydroxytoluene (0.2 mg/mL). Benzo(a)pyrene metabolites were extracted twice with ethyl acetate. The organic
layer was removed and evaporated under nitrogen. Each
sample residue was dissolved in 500 lL methanol, passed
through Acrodisc ﬁlters (0.45 lm; 25 mm diameter, Gelman Sciences, Ann Arbor, MI), and subjected to reversephase HPLC for analyses of BaP metabolites as described
previously (Ramesh et al., 2001). Benzo(a)pyrene metabolite standards were obtained from the National Cancer Institute Chemical Carcinogen Repository (Midwest Research
Institute, Kansas City, MO). Though this analytical method
was set-up originally for the rat, it was optimized for other
species analyzed in our laboratory (Walker et al., 2006).
Controls were processed in parallel with experimental samples under identical assay conditions. Dimethyl sulfoxide
(vehicle for BaP) was used as a negative control while reaction mixtures without BaP or microsomes served as positive
controls. All incubations were performed in triplicate for
each ovarian and hepatic microsomal sample. The variability among triplicates was less than 10%. The rates of BaP
metabolism (formation of BaP metabolites) were expressed
as pmol of product formed per min per mg of microsomal
protein. Because BaP and its metabolites are suspected carcinogens, they were handled in accordance with NIH guidelines for preventing exposure of laboratory personnel to this
chemical (NIH, 1981).

Effect of Estrous Cycle on BaP Metabolism
To delineate the inﬂuence of different phases of estrous
cycle on BaP metabolism, ovaries from commercial crossbred prepubertal gilts (7–8 month old; ovaries with follicles
and no corpora lutea) and those of postpubertal gilts (ova-
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ries with corpora lutea of various stages of development or
corpora albicantia) were used.

Statistics
Data on microsomal mean BaP metabolite concentrations
were analyzed by ANOVA with repeated measures and the
differences among means were tested for signiﬁcance by
orthogonal contrasts (Steel and Torrie, 1980).

RESULTS AND DISCUSSION
The concentration of BaP (5 lM) used in the present study
is higher than the actual concentrations (0.025–0.086 ng/g
wet tissue) reported in the liver, lung, and breast of healthy
humans and smokers (Beach et al., 2000; Goldman et al.,
2001). Nonetheless, this concentration was chosen because
of its relevance to environmental levels of BaP in hazardous waste sites, former industrial sites, and exposure concentrations for ‘‘at risk’’ populations such as smokers and
occupationally exposed individuals (IPCS, 1998; Ramesh
et al., 2004).
Before incubation of microsomes with BaP, ovarian tissue homogenates were analyzed for the presence of BaP
parent compound or its metabolites to ensure their absence
in as much as they (BaP and its metabolites) could be
imposed by diet on organs of farm animals in particular.
Subsequent to incubation of microsomes with BaP, no
unmetabolized BaP (parent compound) was detected.
Regardless of species, ovary and liver microsomes exhibited the capability to metabolize BaP based on detected levels of metabolites, which were absent in the control reaction
mixtures (P \ 0.005). The concentrations of BaP metabolites produced by the ovarian microsomes varied among the
species. The in vitro metabolism of BaP was highest in the
cow and lowest in the mouse (cow [ pig [ goat [ sheep
[ rat [ mouse; treatment 3 species interaction, P \
0.005). Compared to rodents, the BaP metabolite concentrations produced by porcine, ovine, and bovine ovarian microsomes were higher (P \ 0.05; Fig. 1). The total BaP
metabolite concentration proﬁles of hepatic microsomes for
the above mentioned species were similar to those of their
respective ovaries. The overall metabolite concentrations in
liver were species-dependent and rodents had the least concentration of BaP metabolites (P \ 0.05; treatment 3 organ
3 species) compared with the other species. Substantial
differences in ovarian and liver microsomal metabolism of
BaP exist among the various species tested. Results of
cross-species comparison of metabolite concentrations are
shown in Figure 2. Data reported in Figure 1 was subjected
to individual species-wise comparison, which showed that
the differences in metabolite concentrations were statistically signiﬁcant (P \ 0.0001) in the two organs studied.

Environmental Toxicology DOI 10.1002/tox
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Fig. 1. Comparison of the metabolism of benzo(a)pyrene in ovarian and hepatic microsomes of rat, mouse, sheep, goat, pig, and cow. Values are expressed as mean concentration of total metabolites 1 SE (n 5 5 for each species). Data from triplicate determination (variability was \10%) of ﬁve individual animals from each species were compared.
Asterisks denote statistical signiﬁcance (P \ 0.05) in BaP metabolite concentrations
between rat and the rest of the animal species.

Multiple species comparison of this data, performed by
two-way ANOVA also revealed that the differences were
statistically signiﬁcant (P \ 0.001) between rodents (rat
and mouse) and higher mammals (ram, pig, and cow).
Additionally, even among the higher mammals, in a majority of the cases, the differences in metabolite concentrations
were different (P \ 0.001) both in ovary and liver (Fig. 1).
Interestingly, hepatic microsomes produced the greatest
quantities of metabolites relative to that of ovarian microsomes in all the species studied (P \ 0.05; Fig. 1). This observation is not surprising in as much as the liver functions
as the main detoxifying organ in mammals (Wall et al.,
1991). The variation in production of BaP metabolites by
microsomes in animal groups used in this study could be
attributed to differences in constitutive levels of drug
metabolizing enzymes (Lewis et al., 1998). Also, induction
of microsomal enzymes by dietary ingredients (Ioannides,
1999) especially in farm animals cannot be ruled out.

Since it is established that metabolism of PAHs in mammalian ovary is hormonally regulated (Bengtsson et al.,
1987), we measured the BaP metabolite concentrations produced by microsomes isolated from prepubertal and cycling
pigs and established that BaP metabolism was indeed inﬂuenced by stage of the sexual development. Microsomes isolated from gilts that were at mid-luteal and follicular phases
metabolized BaP rapidly, compared to those in the prepubertal stage (Table I). Normally, one would expect to see
increased concentrations of BaP metabolites in the ovaries
of cycling than prepubertal pigs because the cycling animals secrete more ovarian steroids (estrogen and progesterone) by antral follicles of different stages of maturation and
the corpora lutea (CL) (Archibong, 1987). On the contrary,
the high concentrations of metabolites in luteal phase are
not uncommon due to a high constitutive expression of
CYP-regulated luteal estrogen. Our ﬁndings are in agreement with those of Eliasson et al. (1997) who reported that

Fig. 2. Metabolite proﬁles of benzo(a)pyrene in ovary and liver microsomes of rat, mouse,
sheep, goat, pig, and cow. Values are expressed as the percentage of individual metabolite types among the total metabolites (sum of individual concentrations of BaP 9,10-diol;
BaP 4,5-diol; BaP 7,8-diol; 1-hydroxy, 3-hydroxy, and 9-hydroxy BaP) formed; n 5 5 for
each species.

Environmental Toxicology DOI 10.1002/tox
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TABLE I. Benzo(a)pyrene metabolite concentrations generated by microsomes from various stages of estrous cycle
in pig

Ovarian Status
Prepubertal (n 5 6)
Prepubertal (n 5 4)
Postpubertal (n 5 2)
Postpubertal (n 5 5)

BaP Metabolite Concentrations
(pmoles/min/mg protein)

Description
Minimal estrogen stimulation of the uterus
Some uterine stimulation
Follicular to late follicular phases, 14–15CA, many 4–5 mm follicles
Mid-luteal, 11–17 CL

0.10 6 0.0001****
0.12 6 0.01***
0.17 6 0.02**
0.22 6 0.02

CA, corpora albicans; CL, corpus luteum.
****
P \ 0.0001; prepubertal (minimal estrogen stimulation) versus postpubertal (follicular and mid-luteal).
***
P \ 0.001; prepubertal (some estrogen stimulation) versus postpubertal (follicular and mid-luteal).
**
P \ 0.01; prepubertal (some estrogen stimulation) versus postpubertal (follicular).

metabolism of dimethylbenz(a)anthracene was highest in
CL compared to preovulatory follicles. Furthermore, the
higher concentrations of BaP metabolites in the CL, particularly the metabolites in the organic fraction (less polar)
could be secondary to the higher lipid content of the CL.
Benzo(a)pyrene metabolites, being lipid soluble are
transported across the cell membrane by passive diffusion
(Castelli et al., 2002), enter the germ cells and may cause
apoptosis (Mattison et al., 1985) leading to ovarian follicular atresia (Hsueh et al., 1994; Mann et al., 1999; Savabieasfahani et al., 1999). Information on the composition of
metabolites that arise from bioactivation of BaP in the presence of microsomes is relevant in understanding the causal
factors involved in toxicity. Initial oxidation of BaP catalyzed by CYP450 family of enzymes (CYP1A1, CYP1A2,
and CYP1B1) yield arene oxides (9-OH-BaP, 7-OH-BaP,
6-OH-BaP, 3-OH-BaP, and 1-OH-BaP). These arene oxides
rearrange to phenols or undergo hydration catalyzed by
epoxide hydrolase (EH) generating BaP-9,10-diol; BaP7,8-diol; and BaP-4,5-diol (reviewed in Ramesh et al.,
2004; Shimada and Guengerich, 2006). Of the drug metabolizing enzymes that contribute to differential susceptibilities to the toxic effects of BaP, the CYP1A1 is not constitutively expressed in various species and CYP1A2 is
mostly hepatic (Guengerich, 1997). Therefore, the biotransformation of BaP by ovarian microsomes could have been
the result of CYP1B1 and EH that were reported to be constitutively expressed in ovarian tissues (DiBiasio et al.,
1991; Otto et al., 1992). One of the products of BaP biotransformation, the BaP-7,8-diol is further oxidized to
7,8,9,10-tetrahydrobenzo(a)pyrene (BPDE). This diol epoxide reacts with cellular macromolecules and cause toxicity
(Xue and Warshawsky, 2005).
The BaP metabolites identiﬁed from both ovary and
liver tissues were BaP 9,10-diol, BaP 4,5-diol, BaP 7,8diol, 3-hydroxy and 9-hydroxy BaP. There were no remarkable differences between hepatic and ovarian microsomes
in the BaP metabolite types formed. The rodent ovarian microsomes produced considerably higher proportion (P \
0.05; treatment 3 species interaction) of BaP 4,5-diol, and

7,8-diol than the other animal species in this study. However,
hepatic microsomes from the latter animal groups converted
a greater proportion than rodents (P \ 0.05; treatment 3 species interaction) of BaP to 3- and 9-hydroxy BaP that are
considered to be a part of the detoxiﬁcation pathway.
Using estrogen receptor binding assays BaP/metabolites
were estrogen antagonists (Arcaro et al., 1999). Furthermore, in vivo studies conducted in our laboratory have
revealed that sub acute exposure to BaP resulted in antiestrogenic activities (Archibong et al., 2002) that are driven
by BaP metabolism. Interestingly, the microsomal CYP
families of enzymes that generate these metabolites in liver
and extra hepatic tissues such as the ovary are also involved
in steroid hormone metabolism (Jefcoate et al., 2000).
Upon prolonged exposure to BaP, sequestration of this
chemical in high-density lipoproteins (Polyakov et al.,
1996) that are essential for steroid hormone biosynthesis in
the ovary cannot be ruled out. This can lead to reduced
secretion of gonadotropins such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH) at proestrus in
lower mammalian species and at ovulatory phase of the
menstrual cycle of women with adverse outcomes in the
ﬁnal stages of follicular development (Neal et al., 2007).
Extrapolation of in vitro data to in vivo situation has some
limitations in that, especially in farm animals, the likelihood of more amounts of biotransformation enzymes in one
species and an intrinsically greater rate of clearance cannot
be ruled out. Toward this end, our long-term goal is to
study the biotransformation enzyme activities, expression
and kinetic parameters, and the inhibition proﬁles for ovarian microsomes of each species and compare those obtained
for human ovarian microsomes to assess the animal species
most similar to humans who are exposed to PAHs via
cigarette smoke, occupational settings, and diet.

Mention of trade names or commercial products is solely for
the purpose of providing information and does not imply recommendation, endorsement, or exclusion of other suitable products
by the U.S. Department of Agriculture. The contents of the
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publication are solely the responsibility of the authors and do not
necessarily represent the ofﬁcial views of NIH or USDA or
Meharry Medical College.
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